|
Volumn 31, Issue 3, 2013, Pages 184-186
|
Personalized, sequencing-based immune profiling spurs startups.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
IMMUNOGLOBULIN RECEPTOR;
BIOTECHNOLOGY;
GENETICS;
GENOMICS;
HIGH THROUGHPUT SEQUENCING;
HUMAN;
IMMUNITY;
METHODOLOGY;
MINIMAL RESIDUAL DISEASE;
NOTE;
PERSONALIZED MEDICINE;
POLYMERASE CHAIN REACTION;
ANTIBODIES;
BIOTECHNOLOGY;
GENOMICS;
HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING;
HUMANS;
IMMUNE SYSTEM PHENOMENA;
INDIVIDUALIZED MEDICINE;
NEOPLASM, RESIDUAL;
POLYMERASE CHAIN REACTION;
RECEPTORS, IMMUNOLOGIC;
|
EID: 84883001595
PISSN: None
EISSN: 15461696
Source Type: None
DOI: 10.1038/nbt0313-184b Document Type: Note |
Times cited : (6)
|
References (0)
|